Drug Type Small molecule drug |
Synonyms Compound 7 |
Target |
Mechanism 20S proteasome inhibitors(20S proteasome inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H18ClF2N3O3 |
InChIKeyNTOVJWIULULGGI-GFCCVEGCSA-N |
CAS Registry2827061-47-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Trypanosomiasis, African | Preclinical | US | 28 Sep 2022 |